Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Current Assets (2017 - 2024)

KalVista Pharmaceuticals' Current Assets history spans 10 years, with the latest figure at $286.0 million for Q4 2024.

  • For Q4 2024, Current Assets changed N/A year-over-year to $286.0 million; the TTM value through Dec 2024 reached $286.0 million, changed N/A, while the annual FY2024 figure was $225.7 million, N/A changed from the prior year.
  • Current Assets for Q4 2024 was $286.0 million at KalVista Pharmaceuticals, up from $152.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $286.0 million in Q4 2024 and bottomed at $62.5 million in Q1 2021.
  • The 4-year median for Current Assets is $116.4 million (2023), against an average of $136.7 million.
  • The largest annual shift saw Current Assets crashed 36.87% in 2021 before it increased 27.89% in 2024.
  • A 4-year view of Current Assets shows it stood at $72.1 million in 2020, then decreased by 13.28% to $62.5 million in 2021, then surged by 105.76% to $128.6 million in 2023, then surged by 122.37% to $286.0 million in 2024.
  • Per Business Quant, the three most recent readings for KALV's Current Assets are $286.0 million (Q4 2024), $152.3 million (Q4 2024), and $191.6 million (Q3 2024).